Bayer Aktiengesellschaft (VIE:BAYN)

Austria flag Austria · Delayed Price · Currency is EUR
22.53
-0.23 (-0.99%)
Last updated: Mar 27, 2025
Market Cap 22.17B
Revenue (ttm) 46.61B
Net Income (ttm) -2.55B
Shares Out n/a
EPS (ttm) -2.60
PE Ratio n/a
Forward PE n/a
Dividend 0.11 (0.49%)
Ex-Dividend Date Apr 28, 2025
Volume 153
Average Volume 3,247
Open 22.40
Previous Close 22.75
Day's Range 22.38 - 22.53
52-Week Range 18.22 - 30.91
Beta n/a
RSI 46.79
Earnings Date Mar 5, 2025

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skinca... [Read more]

Industry Chemicals and Allied Products
Founded 1863
Employees 90,587
Stock Exchange Vienna Stock Exchange
Ticker Symbol BAYN
Full Company Profile

Financial Performance

In 2024, Bayer Aktiengesellschaft's revenue was 46.61 billion, a decrease of -2.16% compared to the previous year's 47.64 billion. Losses were -2.55 billion, -13.23% less than in 2023.

Financial Statements

News

There is no news available yet.